Digital mental health specialist Woebot raises $90mInvestments in digital health firms are running high at the moment, and a $90 million round for four-year-old Share XDigital mental health specialist Woebot raises $90mhttps://pharmaphorum.com/news/digital-mental-health-specialist-woebot-raises-90m/
Common but not normal: It’s time to talk about maternal mental healthAs part of our Patients Insights series, the founder and CEO of Motherhood Understood shares her experience of Share XCommon but not normal: It’s time to talk about maternal mental healthhttps://pharmaphorum.com/views-analysis-patients/common-but-not-normal-its-time-to-talk-about-maternal-mental-health/
Sage soars on postpartum depression dataSage Therapeutics has scored a big win with postpartum depression (PPD) drug SAGE-217, after rolling the dice on Share XSage soars on postpartum depression datahttps://pharmaphorum.com/news/sage-soars-on-postpartum-depression-data/
